These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10570785

  • 1. [Precocious puberty, Gh deficiency and obesity can affect final height in patients with myelomeningocele: comparison of males and females].
    Galluzzi F, Bindi G, Poggi G, Rossi S, Danti DA, Salti R.
    Pediatr Med Chir; 1999; 21(2):73-8. PubMed ID: 10570785
    [Abstract] [Full Text] [Related]

  • 2. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
    August GP, Julius JR, Blethen SL.
    Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
    [Abstract] [Full Text] [Related]

  • 3. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Nov; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 8. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C, Couto-Silva AC, Sainte-Rose C, Chemaitilly W, Kalifa C, Doz F, Zerah M, Brauner R.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [Abstract] [Full Text] [Related]

  • 9. Precocious puberty and statural growth.
    Carel JC, Lahlou N, Roger M, Chaussain JL.
    Hum Reprod Update; 2004 Aug; 10(2):135-47. PubMed ID: 15073143
    [Abstract] [Full Text] [Related]

  • 10. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 11. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [Abstract] [Full Text] [Related]

  • 20. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 May; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.